30
Participants
Start Date
May 31, 2011
Primary Completion Date
March 5, 2018
Study Completion Date
March 5, 2018
Placebo
Children aged 7-11 years old will receive placebo 200 mg three times a day (TID), while children older than 12 will receive Placebo 400 mg TID.
Guaifenesin
Children aged 7-11 years old will receive guaifenesin 200 mg TID, while children older than 12 will receive guaifenesin 400 mg TID.
Virginia Commonwealth University Children's Hospital of Richmond, Children's Pavilion & Nelson Clinic, Richmond
Collaborators (1)
Pfizer
INDUSTRY
Virginia Commonwealth University
OTHER